Doximity (NASDAQ:DOCS) Coverage Initiated at BMO Capital Markets

Investment analysts at BMO Capital Markets began coverage on shares of Doximity (NASDAQ:DOCS) in a note issued to investors on Thursday, MarketBeat.com reports. The firm set a “market perform” rating and a $55.00 price target on the stock. BMO Capital Markets’ price target indicates a potential upside of 10.84% from the stock’s current price.

A number of other equities analysts have also issued reports on the stock. Bank of America upgraded shares of Doximity from a “neutral” rating to a “buy” rating and upped their target price for the stock from $75.00 to $82.00 in a research report on Monday, October 27th. Piper Sandler upped their price objective on Doximity from $65.00 to $69.00 and gave the stock an “overweight” rating in a report on Monday, August 11th. Raymond James Financial set a $75.00 price objective on Doximity in a research report on Wednesday, September 10th. The Goldman Sachs Group set a $64.00 target price on Doximity and gave the stock a “sell” rating in a research report on Wednesday, October 1st. Finally, Needham & Company LLC upped their price target on Doximity from $67.00 to $75.00 and gave the company a “buy” rating in a research note on Friday, August 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat, Doximity currently has a consensus rating of “Hold” and an average price target of $68.78.

Doximity Stock Performance

Shares of DOCS stock opened at $49.62 on Thursday. Doximity has a 52 week low of $47.66 and a 52 week high of $85.21. The stock has a market capitalization of $9.29 billion, a PE ratio of 49.62, a PEG ratio of 4.10 and a beta of 1.36. The stock’s fifty day moving average is $67.58 and its 200-day moving average is $62.46.

Doximity (NASDAQ:DOCS) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.38 by $0.07. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same period in the previous year, the business earned $0.30 earnings per share. Doximity’s revenue for the quarter was up 23.2% on a year-over-year basis. Doximity has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. As a group, analysts forecast that Doximity will post 0.99 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, Director Regina M. Benjamin sold 5,000 shares of the company’s stock in a transaction dated Friday, October 10th. The stock was sold at an average price of $70.84, for a total value of $354,200.00. Following the completion of the sale, the director owned 19,839 shares in the company, valued at approximately $1,405,394.76. This represents a 20.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director Kira Scherer Wampler sold 2,000 shares of the stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $66.44, for a total value of $132,880.00. Following the completion of the transaction, the director directly owned 19,839 shares in the company, valued at $1,318,103.16. The trade was a 9.16% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 32,000 shares of company stock valued at $2,339,580 over the last three months. Company insiders own 31.30% of the company’s stock.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently bought and sold shares of the company. Voya Investment Management LLC increased its stake in Doximity by 932.8% in the third quarter. Voya Investment Management LLC now owns 1,567,668 shares of the company’s stock valued at $114,267,000 after purchasing an additional 1,415,882 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Doximity by 130.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,966,801 shares of the company’s stock worth $114,133,000 after purchasing an additional 1,113,076 shares in the last quarter. Franklin Resources Inc. grew its holdings in shares of Doximity by 53.9% in the 2nd quarter. Franklin Resources Inc. now owns 3,162,593 shares of the company’s stock valued at $193,993,000 after buying an additional 1,108,162 shares during the period. Capital World Investors increased its position in shares of Doximity by 25.7% in the 3rd quarter. Capital World Investors now owns 5,381,431 shares of the company’s stock valued at $393,652,000 after buying an additional 1,101,848 shares in the last quarter. Finally, Vanguard Group Inc. raised its stake in Doximity by 8.8% during the 1st quarter. Vanguard Group Inc. now owns 12,194,492 shares of the company’s stock worth $707,646,000 after buying an additional 990,923 shares during the period. Institutional investors own 87.19% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.